Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

Cites (495)

Items 201–400 of 483

1. European evidenced-based consensus on reproduction in inflammatory bowel disease
   C. Janneke van der Woude, Sanja Kolaček, Iris Dotan, Tom Öresland, Séverine Vermeire, Pia Munkholm, Uma Mahadevan, Lucy H. Mackillop, Axel U Dignass · 2010 · Journal of Crohn s and Colitis
2. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis
   Paolo Gionchetti, Fernando Rizzello, A. Venturi, Maurizio Ferretti, Clorinda Brignola, M. Miglioli, Massimo Campieri · 1998 · Diseases of the Colon & Rectum
3. Incidence of third-degree perineal tears in labour and outcome after primary repair.
   C J Walsh, E. F. Mooney, G J Upton, ROGER W. MOTSON · 1996 · PubMed
4. Evaluation of the Learning Curve in Ileal Pouch–Anal Anastomosis Surgery
   Paris P Tekkis, Victor W. Fazio, Ian C. Lavery, Feza H. Remzi, Antony J. Senagore, James S. Wu, Scott A. Strong, Jan D. Poloneicki, Tracy Lynn Hull, James M. Church · 2005 · Annals of Surgery
5. Clostridium difficile Infection in the Inflammatory Bowel Disease Patient
   Adam M. Berg, Ciarán P. Kelly, Francis A. Farraye · 2012 · Inflammatory Bowel Diseases
6. Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
   William J. Sandborn, Joshua R. Korzenik, Bret A. Lashner, Jonathan A. Leighton, Uma Mahadevan, James F. Marion, Michael A. Safdi, Charles A. Sninsky, Raman M. Patel, Keith Friedenberg et al. · 2010 · Gastroenterology
7. A Meta-Analysis of the Placebo Rates of Remission and Response in Clinical Trials of Active Ulcerative Colitis
   Chinyu G. Su, James D. Lewis, Brittany E. Goldberg, Colleen M Brensinger, Gary R. Lichtenstein · 2006 · Gastroenterology
8. Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial
   Gert Van Assche, William J. Sandborn, Brian G. Feagan, Bruce A. Salzberg, D Silvers, Paul S. Monroe, William M. Pandak, Frank Anderson, John F. Valentine, Gary Wild et al. · 2006 · Gut
9. Toxic megacolon
   Daniel Autenrieth, Daniel C. Baumgart · 2011 · Inflammatory Bowel Diseases
10. Abatacept for Crohn's Disease and Ulcerative Colitis
    William J. Sandborn, Jean‐Frédéric Colombel, Bruce E. Sands, Paul J. Rutgeerts, Stephan R. Targan, Remo Panaccione, Brian L. Bressler, K. Geboes, Stefan Schreiber, Richard Aranda et al. · 2012 · Gastroenterology
11. Infliximab for Inflammatory Bowel Disease in Denmark 1999–2005: Clinical Outcome and Follow-Up Evaluation of Malignancy and Mortality
    Sarah Caspersen, Margarita Elkjær, Lene Buhl Riis, Natalia Konstantinovich Pedersen, Christian Mortensen, Tine Jess, Pernille Sarto, Tanja S. Hansen, Vibeke Wewer, Flemming Bendtsen et al. · 2008 · Clinical Gastroenterology and Hepatology
12. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis
    Charlie W. Lees, D. Heys, Gwo‐Tzer Ho, Colin L. Noble, Alan G. Shand, Craig Mowat, Robert Boulton-Jones, A. WILLIAMS, Neal G. Church, Jack Satsangi et al. · 2007 · Alimentary Pharmacology & Therapeutics
13. Association Between the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and Outcomes in Acute Severe Ulcerative Colitis
    C. Corte, Nilesh Fernandopulle, A. M. Catuneanu, Daniel C Burger, M. Cesarini, Lydia White, Satish Keshav, Simon P.L. Travis · 2015 · Journal of Crohn s and Colitis
14. Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis
    Carbonnel, Gargouri, Marc Lémann, Beaugerie, Cattan, Cosnes, Gendre · 2000 · Alimentary Pharmacology & Therapeutics
15. Combination Immunomodulator and Antibiotic Treatment in Patients With Inflammatory Bowel Disease and Clostridium difficile Infection
    Shomron Ben‐Horin, Maya Margalit, Peter J. Bossuyt, Jochen Maul, Yami Shapira, Daniela Bojic, Irit Chermesh, Ahmad Al‐Rifai, Alain M. Schoepfer, Matteo Bosani et al. · 2009 · Clinical Gastroenterology and Hepatology
16. Newly Developed Antibiotic Combination Therapy for Ulcerative Colitis: A Double-Blind Placebo-Controlled Multicenter Trial
    Ohkusa, Toshifumi, Kato, Kimitoshi, Terao, Shuichi, Chiba, Toshimi, Mabe, Katsuhiro, Murakami, Kazunari, Mizokami, Yuji, Sugiyama, Toshiro, Yanaka, Akinori, Takeuchi, Yoshiaki et al. · 2010 · American Journal of Gastroenterology
17. Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: Multi-center open trial
    Osamu Kanauchi, Keiichi Mitsuyama, Terasu Homma, Kazuya Takahama, Yoshihide Fujiyama, Akira Andoh, Yoshio Araki, Suga Toshihiro, Toshifumi Hibi∥, Makoto Naganuma et al. · 2003 · International Journal of Molecular Medicine
18. Does Infliximab Influence Surgical Morbidity of Ileal Pouch-Anal Anastomosis in Patients with Ulcerative Colitis?
    Stefanie J. Schluender, Andrew Ippoliti, Marla Cindy Dubinsky, Eric A. Vasiliauskas, Konstantinos Antonios Papadakis, Ling Mei, Stephan R. Targan, Phillip R. Fleshner · 2007 · Diseases of the Colon & Rectum
19. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease
    Daniel C. Baumgart, Bertram Wiedenmann, Axel U Dignass · 2003 · Alimentary Pharmacology & Therapeutics
20. Meta‐analysis: pre‐operative infliximab treatment and short‐term post‐operative complications in patients with ulcerative colitis
    Zhiping Yang, Qiong Wu, Kaichun Wu, Daiming Fan · 2009 · Alimentary Pharmacology & Therapeutics
21. A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis
    William J. Sandborn, William J. Tremaine, Kenneth W. Schroeder, Kenneth P. Batts, George M. Lawson, Betty L. Steiner, Jay M. Harrison, ALAN R. ZINSMEISTER · 1994 · Gastroenterology
22. Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis
    Pentasa UC Maintenance Study Group, Philip B. Miner, Stephen B. Hanauer, MALCOLM G. ROBINSON, Jerrold Schwartz, Sanjeev Arora · 1995 · Digestive Diseases and Sciences
23. Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis
    Li-Xuan Sang · 2010 · World Journal of Gastroenterology
24. A Prospective Audit of the Complications of Loop Ileostomy Construction and Takedown
    Stephanie García‐Botello, Juan García-Armengol, Eduardo García‐Granero, Alejandro Espí, C. Juan, Fernando López‐Mozos, Salvador Lledó · 2004 · Digestive Surgery
25. Intravenous cyclosporine in attacks of ulcerative colitis
    Franck Carbonnel, Arnaud Boruchowicz, Bernard Duclos, Jean Claude Soulé, Éric Lerebours, Marc Lémann, J Bélaïche, Jean‐Frédéric Colombel, Jacques Cosnes, Jean–Pierre Gendre · 1996 · Digestive Diseases and Sciences
26. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis1
    Douglas S. Levine, Dennis S Riff, Ronald E. Pruitt, Lawrence D. Wruble, George Koval, David J. Sales, John K. Bell, Lorin K. Johnson · 2002 · The American Journal of Gastroenterology
27. Vaginal Delivery After Ileal Pouch-Anal Anastomosis: A Word of Caution
    Feza H. Remzi, Emre Görgün, Jane Bast, Tom Schroeder, Jeffrey Hammel, Elliot H. Philipson, Tracy Lynn Hull, James M. Church, Victor W. Fazio · 2005 · Diseases of the Colon & Rectum
28. Clinical outcomes of ileorectal anastomosis for ulcerative colitis
    André da Luz Moreira, Ravi Pokala Kiran, Ian C. Lavery · 2009 · British journal of surgery
29. High-Dose Methylprednisolone in the Treatment of Active Ulcerative Colitis
    William Rosenberg, Alan Ireland, Derek P. Jewell · 1990 · Journal of Clinical Gastroenterology
30. Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?
    Helenie Kefalakes, Theodoros J. Stylianides, Georgios Amanakis, George C. Kolios · 2009 · European Journal of Clinical Pharmacology
31. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis
    Udayakumar Navaneethan, Saurabh S. Mukewar, Preethi G.K. Venkatesh, Rocío López, Bo Shen · 2011 · Journal of Crohn s and Colitis
32. Fate of the rectal mucosa after rectal mucosectomy and ileoanal anastomosis
    Jacques P. Heppell, Louis H. Weiland, Jean F Perrault, John H. Pembérton, Robert L. Telander, Robert W. Beart · 1983 · Diseases of the Colon & Rectum
33. Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab
    Waqqas Afif, Jonathan A. Leighton, Stephen B. Hanauer, Edward V. Loftus, William A. Faubion, Darrell S. Pardi, William J. Tremaine, Sunanda V. Kane, David H. Bruining, Russell D. Cohen et al. · 2009 · Inflammatory Bowel Diseases
34. Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets
    Ralph Wright, Sidney Truelove · 1966 · Digestive Diseases and Sciences
35. Leukocytapheresis in Ulcerative Colitis: Results of a Multicenter Double-Blind Prospective Case-Control Study with Sham Apheresis as Placebo Treatment
    Koji Sawada, Kazuo Kusugami, Yasuo Suzuki, Tadao Bamba, Akihiro Munakata, Toshifumi Hibi∥, Takashi Shimoyama · 2005 · The American Journal of Gastroenterology
36. A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis
    Tadao Bamba, Osamu Kanauchi, Akira Andoh, Yoshihide Fujiyama · 2002 · Journal of Gastroenterology and Hepatology
37. Probiotic Escherichia coli Nissle 1917 (EcN) for Successful Remission Maintenance of Ulcerative Colitis in Children and Adolescents: an Open-Label Pilot Study
    Jobst Henker, Sven Muller, M Laass, A Schreiner, Juergen Schulze · 2008 · Zeitschrift für Gastroenterologie
38. Subtotal Colectomy for Severe Acute Colitis: A 20-Year Experience of a Tertiary Care Center with an Aggressive and Early Surgical Policy
    Arnaud Alvès, Yves H. Panis, Yoram Bouhnik, Vincent Maylin, Anne Lavergne‐Slove, Patrice D. Valleur · 2003 · Journal of the American College of Surgeons
39. Volume analysis of outcome following restorative proctocolectomy
    Elaine Marie Burns, Alex Bottle, Paul P Aylin, Susan K. Clark, Paris P Tekkis, Ara Wardkes Darzi, R J Nicholls, Omar D. Faiz · 2010 · British journal of surgery
40. Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal
    A. Cassinotti, Giovanni Clemente Actis, Piergiorgio Duca, A. Massari, Elisabetta Marta Colombo, Elisa Gai, Vito Annese, Giuseppe D'Albasio, Gianpiero Manes, Simon P.L. Travis et al. · 2009 · The American Journal of Gastroenterology
41. Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications
    G. M. Hyde, Derek P. Jewell, M G W Kettlewell, N. J. Mc. C. Mortensen · 2001 · Diseases of the Colon & Rectum
42. Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit
    Ruairi W. Lynch, Derek Lowe, A. Protheroe, Richard Driscoll, Jonathan Michael Rhodes, Ian D. Arnott · 2013 · Alimentary Pharmacology & Therapeutics
43. Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine
    Tom Tang, Stephan R. Targan, Z.-S. Li, Cheng Xu, Vera S. Byers, William J. Sandborn · 2010 · Alimentary Pharmacology & Therapeutics
44. Infliximab, Azathioprine, or Infliximab + Azathioprine for Treatment of Moderate to Severe Ulcerative Colitis: The UC Success Trial
    Remo Panccione, Subrata K. Ghosh, Stephen J. Middleton, Juan Ricardo Márquez, И. Л. Халиф, Laurence Flint, Hubert van Hoogstraten, Hanzhe Zheng, Silvio Danese, Paul J. Rutgeerts · 2011 · Gastroenterology
45. Double-Blind Comparison of Slow-Release 5-Aminosalicylateand Sulfasalazine in Remission Maintenance in Ulcerative Colitis
    Chris Jacob Johan Mulder, G. N. J. Tytgat, Irene T. Weterman, W Dekker, Paul Blok, Max Schrijver, H. van der Heide · 1988 · Gastroenterology
46. Balsalazide Is Superior to Mesalamine in the Time to Improvement of Signs and Symptoms of Acute Mild-to-Moderate Ulcerative Colitis
    Ronald E. Pruitt, John Hanson, Michael A. Safdi, Lawrence D. Wruble, Robert Hardi, John F. Johanson, George Koval, Dennis S Riff, Barry Winston, Amanda Jane Cross et al. · 2002 · The American Journal of Gastroenterology
47. Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease
    M‐H. Jen, Sonia K Saxena, Alex Bottle, Paul P Aylin, Richard Pollok · 2011 · Alimentary Pharmacology & Therapeutics
48. Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials
    Miguel D. Regueiro, Edward V. Loftus, Hillary Steinhart, Russell D. Cohen · 2006 · Inflammatory Bowel Diseases
49. Laparoscopic-Assisted vs. Open Ileal Pouch-Anal Anastomosis: Functional Outcome in a Case-Matched Series
    David W. Larson, Eric J. Dozois, Karen Piotrowicz, Robert R. Cima, Bruce G. Wolff, Tonia M. Young‐Fadok · 2005 · Diseases of the Colon & Rectum
50. A Review of Mortality and Surgery in Ulcerative Colitis
    Charles Noah Bernstein, Siew C. Ng, Peter Laszlo Lakatos, Bjørn Allan Moum, Edward V. Loftus · 2013 · Inflammatory Bowel Diseases
51. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006
    Simon L. Jakobovits, D P Jewell, Simon P.L. Travis · 2007 · Alimentary Pharmacology & Therapeutics
52. Azathioprine or 6-Mercaptopurine Before Colectomy for Ulcerative Colitis Is Not Associated With Increased Postoperative Complications
    Uma Mahadevan, Edward V. Loftus, William J. Tremaine, John H. Pembérton, William Scott Harmsen, Cathy D. Schleck, Alan R. Zinsmeister, William J. Sandborn · 2002 · Inflammatory Bowel Diseases
53. Long‐term effect of tacrolimus therapy in patients with refractory ulcerative colitis
    S. YAMAMOTO, Hiroshi Nakase, S. MIKAMI, Satoko Inoue, Takayuki Yoshino, Yasuhiro Takeda, Katsuhiro Kasahara, S. UENO, Norimitsu Uza, Hiroshi Kitamura et al. · 2008 · Alimentary Pharmacology & Therapeutics
54. A Meta-Analysis of the Efficacy of Sulfasalazine in Comparison with 5-Aminosalicylates in the Induction of Improvement and Maintenance of Remission in Patients with Ulcerative Colitis
    Shekoufeh Nikfar, Roja Rahimi, Ali Ranjideh Rezaie, Mohammad Reza Abdollahi · 2008 · Digestive Diseases and Sciences
55. The efficacy of methotrexate for maintaining remission in inflammatory bowel disease
    Alan Gordon Fraser, D. Morton, Dermot P.B. McGovern, Simon P.L. Travis, Derek P. Jewell · 2002 · Alimentary Pharmacology & Therapeutics
56. A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis
    CJ Hawkey, L M Dubé, LV Rountree, PJ Linnen, J F Lancaster · 1997 · Gastroenterology
57. Laparoscopic subtotal colectomy for acute or severe colitis complicating inflammatory bowel disease: A case-matched study in 88 patients
    Cécile Marceau, Arnaud Alvès, Mehdi Ouaïssi, Yoram Bouhnik, Patrice D. Valleur, Yves H. Panis · 2007 · Surgery
58. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses
    Wolfgang Kruis, S Schreiber, D Theuer, J-W Brandes, E Schütz, S Howaldt, B Krakamp, J Hämling, H Mönnikes, Irmtraut Koop et al. · 2001 · Gut
59. Use of antibiotics in the treatment of inflammatory bowel disease
    Molly L. Perencevich, Robert B. Burakoff · 2006 · Inflammatory Bowel Diseases
60. Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers
    Simon P.L. Travis, Jack Satsangi, Marc Lémann · 2010 · Gut
61. Azathioprine in Steroid-Resistant and Steroid-Dependent Ulcerative Colitis
    Sandro Ardizzone, F. Molteni, Venerina Imbesi, Simona Bollani, Gabriele Bianchi Porro · 1997 · Journal of Clinical Gastroenterology
62. 52-Week Efficacy of Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Failed Corticosteroids and/or Immunosuppressants
    Walter Reinisch, William J. Sandborn, Remo Panaccione, Bidan Huang, Paul F. Pollack, Andreas Lazar, Roopal B Thakkar · 2013 · Inflammatory Bowel Diseases
63. Effect of oral tacrolimus (FK 506) on steroid‐refractory moderate/severe ulcerative colitis
    Christoph Högenauer, H Wenzl, Thomas Anton Hinterleitner, Wolfgang Petritsch · 2003 · Alimentary Pharmacology & Therapeutics
64. A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis
    Sunanda V. Kane, Dezheng Huo, Kalyani Magnanti · 2003 · Clinical Gastroenterology and Hepatology
65. The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis
    Ajit Sood, Vikas Kaushal, Vandana Midha, Krishan Lal Bhatia, Neena Sood, Vineeta Malhotra · 2002 · Journal of Gastroenterology
66. Adalimumab Therapy Is Associated With Reduced Risk of Hospitalization in Patients With Ulcerative Colitis
    Brian G. Feagan, William J. Sandborn, Andreas Lazar, Roopal B Thakkar, Bidan Huang, Nattanan Reilly, Naijun Chen, Mei Yang, Martha Skup, Parvez M Mulani et al. · 2013 · Gastroenterology
67. Long-Term Outcome and Quality of Life After Continent Ileostomy
    Gürel Neşşar, Victor W. Fazio, Paris P Tekkis, Jason Connor, James S. Wu, Jane Bast, Allison Borkowski, Conor Patrick Delaney, Feza H. Remzi · 2006 · Diseases of the Colon & Rectum
68. Limited exposure of the healthy distal colon to orally‐dosed formulation is further exaggerated in active left‐sided ulcerative colitis
    Hebden, BLACKSHAW, Perkins, Wilson, Robert E. Spiller · 2000 · Alimentary Pharmacology & Therapeutics
69. One- or Two-stage Procedure for Restorative Proctocolectomy
    Udo A. Heuschen, Ulf Hinz, E. H. Allemeyer, Matthias Lucas, Gundi Heuschen, Christian H. Herfarth · 2001 · Annals of Surgery
70. Successive Treatment With Cyclosporine and Infliximab in Steroid-Refractory Ulcerative Colitis
    Sarah Leblanc, Matthieu Allez, Philippe Seksik, Bernard Flourié, Harald Peeters, J L Dupas, Guillaume Bouguen, Laurent Peyrin‐Biroulet, Bernard Duclos, Arnaud Bourreille et al. · 2011 · The American Journal of Gastroenterology
71. Mortality, morbidity and functional outcome after ileorectal anastomosis
    C. Elton, G. Makin, Kerry Hitos, C. Cohen · 2003 · British Journal of Surgery
72. Continuous Infusion Versus Bolus Administration of Steroids in Severe Attacks of Ulcerative Colitis: A Randomized, Double-Blind Trial
    Fabrizio Bossa, Serafina Fiorella, Nazario Caruso, Laura Accadia, Grazia Napolitano, Maria Rosa Valvano, Angelo Andriulli, Vito Annese · 2006 · The American Journal of Gastroenterology
73. Treatment of ulcerative colitis with adalimumab or infliximab: long‐term follow‐up of a single‐centre cohort
    Nicholas Gies, Karen Ivy Kroeker, Karen Wong, Richard Neil Fedorak · 2010 · Alimentary Pharmacology & Therapeutics
74. Small bowel gas in severe ulcerative colitis.
    C. N. Chew, Daniel J. Nolan, D P Jewell · 1991 · Gut
75. Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis
    Paul Fockens, Chris Jacob Johan Mulder, G. N. J. Tytgat, Paul Blok, Jaap Ferwerda · 1995 · European Journal of Gastroenterology & Hepatology
76. Oral beclometasone dipropionate in the treatment of extensive and left‐sided active ulcerative colitis: a multicentre randomised study
    Massimo Campieri, S. Adamo, D. Valpiani, A. D’Arienzo, Giuseppe D'Albasio, M. V. Pitzalis, Pietro Cesari, Tino Casetti, G. N. Castiglione, Fernando Rizzello et al. · 2003 · Alimentary Pharmacology & Therapeutics
77. Long-Term Use of Mesalamine (Rowasa) Suppositories in Remission Maintenance of Ulcerative Proctitis
    Stephen B. Hanauer, Larry I. Good, Michael W Goodman, Ronald J Pizinger, Williamson B. Strum, Carl Lyss, Gregory B. Haber, Noel C. Williams, MALCOLM G. ROBINSON · 2000 · The American Journal of Gastroenterology
78. Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study
    Philippe R. Marteau, J. Crand, M Foucault, J C Rambaud · 1998 · Gut
79. Basiliximab for the treatment of steroid‐resistant ulcerative colitis: further experience in moderate and severe disease
    Tom Creed, Christopher S. Probert, Michael Norman, Morgan Moorghen, Neil A. Shepherd, Stephen D. Hearing, Colin Mark Dayan, THE BASBUC INVESTIGATORS · 2006 · Alimentary Pharmacology & Therapeutics
80. Subtotal colectomy for ulcerative colitis
    Frank M. Carter, Robin S. McLeod, Zane Cohen · 1991 · Diseases of the Colon & Rectum
81. ULCERATIVE COLITIS COURSE AND PROGNOSIS
    J.M. Rice-Oxley, Sidney Truelove · 1950 · The Lancet
82. Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
    Carlos Taxonera, J. Estellés, Ignacio Fernández-Blanco, Olga Merino, Ignacio Marín‐Jiménez, Manuel Barreiro‐de Acosta, Cristina Morales Saro, Valle García-Sánchez, Elena Gento, Guillermo Bastida et al. · 2010 · Alimentary Pharmacology & Therapeutics
83. Narcotic use for inflammatory bowel disease and risk factors during hospitalization
    Millie D. Long, Edward L. Barnes, Hans H. Herfarth, Douglas A. Drossman · 2011 · Inflammatory Bowel Diseases
84. Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis
    Wulfran Cacheux, Philippe Seksik, Marc Lémann, Philippe R. Marteau, Isabelle Nion–Larmurier, Pauline Afchain, Fady E. Daniel, Laurent Beaugerie, Jacques Cosnes · 2008 · The American Journal of Gastroenterology
85. Functional Outcome and Quality of Life After Repeat Ileal Pouch-Anal Anastomosis for Complications of Ileoanal Surgery
    Jorge Baixauli, Conor Patrick Delaney, James S. Wu, Feza H. Remzi, Ian C. Lavery, Victor W. Fazio · 2004 · Diseases of the Colon & Rectum
86. Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study
    Giovanni Clemente Actis, Maurizio Fadda, Ezio David, Anna Sapino · 2007 · BMC Gastroenterology
87. The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: A long‐term term follow‐up study
    L. Börjesson, Roger Wïllén, Najib Y. Haboubi, Sarah Duff, Leif Hultén · 2004 · Colorectal Disease
88. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohnʼs disease
    Wolfgang Holtmeier, Stefan Zeuzem, J. Preiß, Wolfgang Kruis, Stephan Karl Böhm, Christian Maaser, Andreas Raedler, Carsten Schmidt, Jörg Schnitker, Joachim A. Schwarz et al. · 2010 · Inflammatory Bowel Diseases
89. Management of acute severe colitis
    Simon L. Jakobovits, Simon P.L. Travis · 2005 · British Medical Bulletin
90. Urgent Subtotal Colectomy for Severe Inflammatory Bowel Disease
    Neil Hyman, Peter A. Cataldo, Turner M. Osler · 2004 · Diseases of the Colon & Rectum
91. Ileal Pouch–Anal Anastomosis
    Jennifer Rose Chapman · 2005 · Archives of Surgery
92. Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators
    Venkataraman Subramanian, Richard Pollok, J-Y Kang, D Kumar · 2006 · British journal of surgery
93. Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine
    Mahmood Wahed, John Louis-Auguste, Louisa M. Baxter, Jimmy K. Limdi, Sara A McCartney, James Oliver Lindsay, Stuart L Bloom · 2009 · Alimentary Pharmacology & Therapeutics
94. Long-term results of ileorectal anastomosis in ulcerative colitis in Stockholm County
    Carl-Eric Leijonmarck, Robert Löfberg, Åke Öst, Goran Hellers · 1990 · Diseases of the Colon & Rectum
95. Ileal pouch-anal anastomosis without ileostomy
    Susan Galandiuk, Bruce G. Wolff, Roger R. Dozois, Robert W. Beart · 1991 · Diseases of the Colon & Rectum
96. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis
    Pierre-Eugène Mortier, Luc P. Gambiez, Mehdi Karoui, Antoine Cortot, Jean-Claude Paris, Pierre A Quandalle, Jean–Frédéric Colombel · 2006 · Gastroentérologie Clinique et Biologique
97. Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis
    Partha Das, Matt W Johnson, Paris P Tekkis, R J Nicholls · 2006 · Colorectal Disease
98. Appendicectomy as a Therapy for Ulcerative Proctitis
    Terry Dorcen Bolin, Shing Wong, Roger L. Crouch, Jeffrey Lionel Engelman, Stephen M. Riordan · 2009 · The American Journal of Gastroenterology
99. Are There Any Differences in the Efficacy and Safety of Different Formulations of Oral 5-ASA Used for Induction and Maintenance of Remission in Ulcerative Colitis? Evidence from Cochrane Reviews
    Brian G. Feagan, Nilesh Chande, John K MacDonald · 2013 · Inflammatory Bowel Diseases
100. Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis
     Kah Hoong Chang, John Patrick Burke, J. Calvin Coffey · 2012 · International Journal of Colorectal Disease
101. Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: An open-label study
     Laurent Peyrin‐Biroulet · 2007 · World Journal of Gastroenterology
102. Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing - ASCEND I and II combined analysis
     Gary R. Lichtenstein, David J. Ramsey, David T. Rubin · 2011 · Alimentary Pharmacology & Therapeutics
103. Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohnʼs disease: A single-center experience
     Aaron Benson, Terrence A. Barrett, Marshall S. Sparberg, Alan L. Buchman · 2007 · Inflammatory Bowel Diseases
104. A randomized placebo-controlled trial of pegylated interferon alpha in active ulcerative colitis
     Herbert Tilg, Harald Vogelsang, Othmar Ludwiczek, Herbert H. Lochs, Jean–Frédéric Colombel, Paul J. Rutgeerts, Hanno Ulmer, Sandrine Kruger, Antoine Cortot, Geert D’Haens et al. · 2003 · Gastroenterology
105. Long‐term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single‐centre experience
     Abderrahim Oussalah, Cécile Laclotte, Jean‐Baptiste Chevaux, Mouni Bensenane, Abdenour Babouri, Anne-Agathe Serre, T. Boucekkine, Xavier Roblin, Marc‐André Bigard, Laurent Peyrin‐Biroulet · 2008 · Alimentary Pharmacology & Therapeutics
106. Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis
     Michael A. Kamm, Gary R. Lichtenstein, William J. Sandborn, Stefan Schreiber, Kirstin Lees, Karen Barrett, Raymond E. Joseph · 2008 · Inflammatory Bowel Diseases
107. Management of acute severe ulcerative colitis
     Gert Van Assche, Severine A.R.A. Vermeire, Paul Rutgeerts · 2010 · Gut
108. Methotrexate for maintenance of remission in ulcerative colitis
     Yongjun Wang, John K MacDonald, Ben Vandermeer, Anne Marie Griffiths, Wael El‐Matary · 2015 · Cochrane Database of Systematic Reviews
109. Outcomes for Patients Undergoing Continent Ileostomy After a Failed Ileal Pouch-Anal Anastomosis
     Lei Lian, Victor W. Fazio, Feza H. Remzi, Bo Shen, David Dietz, Ravi Pokala Kiran · 2009 · Diseases of the Colon & Rectum
110. Impact of Clostridium difficile colitis on 5‐year health outcomes in patients with ulcerative colitis
     Sanjay K. Murthy, A. Hillary Steinhart, Jill Tinmouth, Peter C. Austin, Nick Daneman, Geoffrey C. Nguyen · 2012 · Alimentary Pharmacology & Therapeutics
111. Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients
     M. Sjöberg, Anders Magnuson, Jan A. Björk, Cecilia Benoni, Sven H. Almer, Ingalill Friis–Liby, Erik Hertervig, Mikael Olsson, Per Karlén, Anders Eriksson et al. · 2013 · Alimentary Pharmacology & Therapeutics
112. Azathioprine without oral ciclosporin in the long‐term maintenance of remission induced by intravenous ciclosporin in severe, steroid‐refractory ulcerative colitis
     Eugeni Domènech, Esther García-Planella, I. Bernal, Mercè Rosinach, Eduard Cabré, Lourdes Fluvià, J. Boix, M.À. Gassull · 2002 · Alimentary Pharmacology & Therapeutics
113. Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis.
     A. Ireland, C Mason, D P Jewell · 1988 · Gut
114. Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis
     Marco Scarpa, Paul J. van Koperen, Dirk T. Ubbink, Daniël W. Hommes, Fiebo J.W. ten Kate, Willem Adrianus Bemelman · 2007 · British journal of surgery
115. Distribution of mesalazine enemas in active and quiescent ulcerative colitis.
     Adriaan Anthonie Van Bodegraven, R. O. Boer, J Lourens, Hans A.R.E. Tuynman, Jan W. Sindram · 1996 · Alimentary Pharmacology & Therapeutics
116. Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double‐blind comparison with sulphasalazine
     Peter Bruce McIntyre, C.A. Rodrigues, J E Lennard‐Jones, Ian G Barrison, Jon Walker, J. H. Baron, P. C. THORNTON · 1988 · Alimentary Pharmacology & Therapeutics
117. Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis
     William J. Sandborn, J.‐F. COLOMBEL, Matthew B. Frankel, Daniël W. Hommes, James N. Lowder, Lauren Mayer, Scott Eric Plevy, Pieter C F Stokkers, Simon P.L. Travis, Gert Van Assche et al. · 2010 · Gut
118. Is maintenance therapy always necessary for patients with ulcerative colitis in remission?
     Sandro Ardizzone, Petrillo, Имбеси, CERUTTI, BOLLANI, Bianchi Porro · 1999 · Alimentary Pharmacology & Therapeutics
119. Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1‐year follow‐up study
     Omero Alessandro Paoluzi, Federico Iacopini, Roberta Pica, Pietro Crispino, Adriana Marcheggiano, Adriana Consolazio, M. Rivera, Paolo Paoluzi · 2005 · Alimentary Pharmacology & Therapeutics
120. The role of azathioprine in the management of ulcerative colitis
     Alan Lobo, P. N. Foster, Dermot Burke, David Annandale Johnston, A. T. R. Axon · 1990 · Diseases of the Colon & Rectum
121. Short‐term efficacy of tacrolimus in steroid‐refractory ulcerative colitis – experience in 130 patients
     K. J. Schmidt, K. R. Herrlinger, Jörg Emmrich, Daniel Nicolas Barthel, Hülya Koç, Hendrik Lehnert, Eduard Friedrich Stange, Klaus Fellermann, Jürgen Büning · 2012 · Alimentary Pharmacology & Therapeutics
122. Local application of tacrolimus in distal colitis: Feasible and safe
     Jolanda M. van Dieren, Adriaan Anthonie Van Bodegraven, Ernst Johan Kuipers, Eke N Bakker, Alexander C. Poen, Herman van Dekken, Edward E. S. Nieuwenhuis, Janneke C. van der Woude · 2008 · Inflammatory Bowel Diseases
123. Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis†
     Liliana Andrade Chebli, Leonardo Duque de Miranda Chaves, Felipe Ferreira Pimentel, Dolores Martins Guerra, Renata Maria de Freitas Barros, Pedro Duarte Gaburri, Alexandre Zanini, Júlio Maria Fonseca Chebli · 2009 · Inflammatory Bowel Diseases
124. Life Events and Inflammatory Bowel Disease Relapse: A Prospective Study of Patients Enrolled in Remission
     Vidal, Angela, Gómez-Gil, Esther, Sans, Miquel, Portella, Maria J, Salamero, Manel, Piqué, Josep M, Panés, Juláin · 2006 · The American Journal of Gastroenterology
125. Clinical trial: ulcerative colitis maintenance treatment with 5‐ASA: a 1‐year, randomized multicentre study comparing MMX® with Asacol®
     Cosimo Prantera, Anna Kohn, Massimo Campieri, R. Caprilli, Mario Cottone, Franco Pallone, Vincenzo Savarino, Giacomo Carlo Sturniolo, Maurizio Li Vecchi, Alfredo Ardia et al. · 2009 · Alimentary Pharmacology & Therapeutics
126. A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis
     Herbert Tilg, H Vogelsang, O Ludwiczek, H Lochs, A Kaser, J-F Colombel, Hanno Ulmer, P Rutgeerts, S Krüger, Antoine Cortot et al. · 2003 · Gut
127. Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis
     Wolfgang Kruis, Laimas Virginijus Jonaitis, Juris Pokrotnieks, Tatyana L. Mikhailova, M. Horynski, M Bátovský, Y Lozynskyy, Yu. M. Zakharash, István András Rácz, K Kull et al. · 2010 · Alimentary Pharmacology & Therapeutics
128. Improved Outcome Due to Increased Experience and Individualized Management of Leaks After Ileal Pouch-Anal Anastomosis
     Manoj J. Raval, Margaret Schnitzler, Brenda I. O’Connor, Zane Cohen, Robin S. McLeod · 2007 · Annals of Surgery
129. Functional Outcome, Quality of Life, and Complications After Ileal Pouch-Anal Anastomosis in Selected Septuagenarians
     Conor Patrick Delaney, Babak Dadvand, Feza H. Remzi, James M. Church, Victor W. Fazio · 2002 · Diseases of the Colon & Rectum
130. Rectal tacrolimus in the treatment of resistant ulcerative proctitis
     Ian Craig Lawrance, Tandy‐Sue Copeland · 2008 · Alimentary Pharmacology & Therapeutics
131. Results of Surgical Removal of the Pouch After Failed Restorative Proctocolectomy
     Mehdi Karoui, Richard G. Cohen, John Malcolm Nicholls · 2004 · Diseases of the Colon & Rectum
132. History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis
     Ashwin N. Ananthakrishnan, Mazen Issa, Dawn Borromeo Beaulieu, Sue Skaros, Josh F. Knox, Kathryn Lemke, Jeanne E. Emmons, Sarah J. Lundeen, Mary Francis Otterson, David G. Binion · 2008 · Inflammatory Bowel Diseases
133. Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: A double-blind, randomized study
     Hiroaki Ito, Mitsuo Iida, Takayuki Matsumoto, Yasuo Suzuki, Hidetaka Sasaki, Toyomitsu Yoshida, Yuichi Takano, Toshifumi Hibi∥ · 2010 · Inflammatory Bowel Diseases
134. Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis
     Daniel C. Baumgart, John K MacDonald, Brian G. Feagan · 2008 · Cochrane Database of Systematic Reviews
135. Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch–anal anastomosis: a case-matched study
     Benjamin Coquet-Reinier, Stéphane Victor Berdah, Jean–Charles Grimaud, David Jérémie Birnbaum, Pierre-Alain Cougard, Marc A. Barthet, Ariadne Desjeux, Vincent Moutardier, Christian Brunet · 2010 · Surgical Endoscopy
136. Infliximab in Steroid-dependent Ulcerative Colitis
     Alessandro Armuzzi, Daniela Pugliese, Silvio Danese, Gianluca Rizzo, Carla Felice, Manuela Marzo, G. Andrisani, Gionata Fiorino, Orsola Raffaella Sociale, Alfredo Papa et al. · 2013 · Inflammatory Bowel Diseases
137. The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year.
     P. M. Riis, POUL ANTHONISEN, Wulff Hr, Ole Folkenborg, O Bonnevie, Marley J. Binder · 1973 · PubMed
138. 5-Aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: a double-blind placebo-controlled clinical trial.
     A. D’Arienzo, A. Panarese, Francesco Paolo D’Armiento, Claudia Lancia, P. Quattrone, Federica Giannattasio, Amedeo Boscaino, Gabriele Mazzacca · 1990 · PubMed
139. Randomised clinical trial: once‐ vs. twice‐daily prolonged‐release mesalazine for active ulcerative colitis
     Bernard Flourié, Hervé Hagège, Gilbert Tucat, Denis Maetz, Xavier Hébuterne, Johan P. Kuyvenhoven, Tan Tg, Marieke J. Pierik, Ad Masclee, Olivier Dewit et al. · 2013 · Alimentary Pharmacology & Therapeutics
140. Minimally Invasive Subtotal Colectomy and Ileal Pouch-Anal Anastomosis for Fulminant Ulcerative Colitis
     Stefan David Holubar, David W. Larson, Eric J. Dozois, Jirawat Pattana-arun, John H. Pembérton, Robert R. Cima · 2009 · Diseases of the Colon & Rectum
141. Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience
     Gianluca Rizzo, Alessandro Armuzzi, Daniela Pugliese, Alessandro Verbo, Alfredo Papa, Claudio Mattana, Gian Lodovico Rapaccini, Luisa Guidi, Claudio Coco · 2011 · International Journal of Colorectal Disease
142. Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis
     Adam S. Cheifetz, Joshua Stern, Sagar S. Garud, Eric S. Goldstein, Lisa B. Malter, Alan C. Moss, Daniel H. Present · 2010 · Journal of Clinical Gastroenterology
143. Laparoscopic Versus Open 2-Stage Ileal Pouch: Laparoscopic Approach Allows for Faster Restoration of Intestinal Continuity
     Alyssa D. Fajardo, Sekhar Dharmarajan, Virgilio V. George, Steven R. Hunt, Elisa H. Birnbaum, James W. Fleshman, Matthew G. Mutch · 2010 · Journal of the American College of Surgeons
144. Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment
     Luca Benazzato, Renata D'Incà, Francesco Grigoletto, Egle Perissinotto, Valentina Medici, Imerio Angriman, G.C. Sturniolo · 2004 · Digestive and Liver Disease
145. Meta‐analysis: the efficacy of rectal beclomethasone dipropionate vs. 5‐aminosalicylic acid in mild to moderate distal ulcerative colitis
     Francesco Manguso, Antonio Balzano · 2007 · Alimentary Pharmacology & Therapeutics
146. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study
     Takayuki Yamamoto, Satoru Umegae, Tatsushi Kitagawa, Y. Yasuda, Yoichi M. A. Yamada, D. Takahashi, Masatoshi Mukumoto, N. Nishimura, K. Yasue, Koichi Matsumoto · 2004 · Alimentary Pharmacology & Therapeutics
147. ULCERATIVE COLITIS: A SURVEY OF NINETY-FIVE CASES
     T.L. Hardy, Ernest Bulmer · 1933 · BMJ
148. Maintenance Treatment of Ulcerative Proctitis With Mesalazine Suppositories: A Double-Blind Placebo-Controlled Trial
     Giuseppe D'Albasio, Omero Alessandro Paoluzi, Massimo Campieri, Bianchi G Porro, Angelo Pera, Cosimo Prantera, G.C. Sturniolo, M. Miglioli · 1998 · The American Journal of Gastroenterology
149. Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis
     Tilo Andus, Andreas Kocjan, Moritz Müser, Andrey Yu. Baranovsky, Tatyana L. Mikhailova, Tatyana D. Zvyagintseva, Andrey E. Dorofeyev, Y Lozynskyy, Ingolf Cascorbi, Manfred Stolte et al. · 2010 · Inflammatory Bowel Diseases
150. Infliximab for Hospitalized Patients With Severe Ulcerative Colitis
     Miguel D. Regueiro, Jennifer D. Curtis, Scott Eric Plevy · 2006 · Journal of Clinical Gastroenterology
151. Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis
     Gerassimos J. Mantzaris, Athanassios Hatzis, Kalliopi Petraki, Charis Spiliadi, Georgios Triantaphyllou · 1994 · Diseases of the Colon & Rectum
152. The effect of appendectomy on the course of ulcerative colitis: a systematic review
     Tjibbe J. Gardenbroek, Emma J. Eshuis, Cyriel Y. Ponsioen, Dirk T. Ubbink, Geert D’Haens, Willem Adrianus Bemelman · 2011 · Colorectal Disease
153. Effect of weekend 5-aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: Results from a randomized controlled study
     Hiroshi Yokoyama, Sho Takagi, Shinichi Kuriyama, Shuichiro Takahashi, Hiroki Takahashi, Masahiro Iwabuchi, Seiichi Takahashi, Yoshitaka Kinouchi, Nobuo Hiwatashi, Ichiro Tsuji et al. · 2007 · Inflammatory Bowel Diseases
154. The “Natural History” of Ulcerative Colitis
     Samuel Meyers, Henry D. Janowitz · 1989 · Journal of Clinical Gastroenterology
155. Randomised clinical trial: delayed-release oral mesalazine 4.8g/day vs. 2.4g/day in endoscopic mucosal healing - ASCEND I and II combined analysis
     Michael F. Picco · 2011 · Yearbook of Gastroenterology
156. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis
     Richard R. Ricketts · 1991 · Journal of Pediatric Surgery
157. Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis
     Giuseppe D'Albasio, Giacomo Trallori, Augusto Ghetti, Mónica Milla, Andrea Nucci, Franco Pacini, Antonio Morettini · 1990 · Diseases of the Colon & Rectum
158. Postoperative Outcome of Colectomy for Pediatric Patients With Ulcerative Colitis
     Dana J. Patton, Neera Gupta, Janet M. Wojcicki, Elizabeth A. Garnett, Kerilyn K. Nobuhara, Melvin B. Heyman · 2010 · Journal of Pediatric Gastroenterology and Nutrition
159. Obstetric sphincter tears and anal incontinence: an observational follow-up study
     Jan Zetterström, Annika López, Bo Holmström, Bengt Nilsson, Åke Tisell, Bo Anzén, Anders F. Mellgren · 2003 · Acta Obstetricia Et Gynecologica Scandinavica
160. Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis
     Giuseppe Frieri, Maria Teresa Pimpo, B. Galletti, Giancarlo Palumbo, Giovanni Corrao, Giovanni Latella, Maria Chiaramonte, R. Caprilli · 2004 · Digestive and Liver Disease
161. Mucosal Assessment for Dysplasia and Cancer in the Ileal Pouch Mucosa in Patients Operated on for Ulcerative Colitis—A 30-Year Follow-Up Study
     Leif Hultén, Roger Wïllén, Ola Nilsson, N. Safarani, Najib Y. Haboubi · 2002 · Diseases of the Colon & Rectum
162. Infliximab Rescue Therapy after Cyclosporin Failure in Steroid-Refractory Ulcerative Colitis
     Míriam Mañosa, Antonio López–Sanromán, Esther García-Planella, Guillermo Bastida, Joaquín Hinojosa, Yago González‐Lama, Helena Masnou, Eugeni Domènech · 2009 · Digestion
163. Retrospective Case Series Analysis of Patients with Inflammatory Bowel Disease on Azathioprine
     Zubair Hanif Khan, John Francis Mayberry, Nicky Spiers, Anthony C.B. Wicks · 2000 · Digestion
164. The Continent ileostomy: long-term durability and patient satisfaction
     Virginia R. Little, Susan Barbour, Theodore R. Schrock, Mark Lane Welton · 1999 · Journal of Gastrointestinal Surgery
165. Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: A systematic review and meta-analysis
     Brian G. Feagan, John K MacDonald · 2012 · Inflammatory Bowel Diseases
166. Mesalamine Foam Enema Versus Mesalamine Liquid Enema in Active Left-Sided Ulcerative Colitis
     Antoine Cortot, Denis Maetz, Eric Degoutte, Olivier Delette, Pierre Meunier, Gie Tan, JB Cazals, Olivier Dewit, Xavier Hébuterne, Sylvain Béorchia et al. · 2008 · The American Journal of Gastroenterology
167. Quality of life before and after proctocolectomy and IPAA in patients with ulcerative proctocolitis – a prospective study
     Ina Berndtsson, Tom Öresland · 2003 · Colorectal Disease
168. 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial
     Volker Groß, Ivan Bunganič, Белоусова Елена Александровна, Tatyana L. Mikhailova, Limas Kupčinskas, Gediminas Kiudelis, Zsolt Tulassay, Libor Gabalec, Andrey E. Dorofeyev, Jeļena Derova et al. · 2010 · Journal of Crohn s and Colitis
169. Infliximab or Cyclosporine as Rescue Therapy in Hospitalized Patients with Steroid-Refractory Ulcerative Colitis: A Retrospective Observational Study
     Mats Sjöberg, Andrea Walch, Mina Meshkat, Anders Gustavsson, Gunnar Järnerot, Harald Vogelsang, Erik Hertervig, Gottfried Novacek, Ingalill Friis–Liby, Lars Blomquist et al. · 2011 · Inflammatory Bowel Diseases
170. The Prophylactic Effect of Salazosulphapyridine in Ulcerative Colitis during Long-Term Treatment
     P Riis, POUL ANTHONISEN, Henrik R. Wulff, Ole Folkenborg, O Bonnevie, Vibeke Binder · 1973 · Scandinavian Journal of Gastroenterology
171. How effective are the usual treatments for ulcerative colitis?
     James R. Bebb, B. B. Scott · 2004 · Alimentary Pharmacology & Therapeutics
172. Oncologic Outcome in Patients With Ulcerative Colitis Associated With Dyplasia or Cancer Who Underwent Stapled or Handsewn Ileal Pouch-Anal Anastomosis
     Wigdan Al-Sukhni, Robin S. McLeod, Helen MacRae, Brenda I. O’Connor, Harden Huang, Zane Cohen · 2010 · Diseases of the Colon & Rectum
173. Patient quality of life after successful restorative proctocolectomy is normal
     David M. Richards, Stephen A. Hughes, Miles H. Irving, Nigel Scott · 2001 · Colorectal Disease
174. Continent Ileostomy: Current Experience
     Eduardo Castillo, Lauren M. Thomassie, Charles B. Whitlow, David A. Margolin, Jasmine Malcolm, David E. Beck · 2005 · Diseases of the Colon & Rectum
175. Azathioprine versus sulfasalazine in maintenance of remission in severe ulcerative colitis.
     Ajit Sood, Vandana Midha, Neena Sood, G Avasthi · 2003 · PubMed
176. MMX mesalazine for the induction of remission of mild‐to‐moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations
     Gary R. Lichtenstein, Michael A. Kamm, William J. Sandborn, Andrew Lyne, R. E. JOSEPH · 2008 · Alimentary Pharmacology & Therapeutics
177. Effect of high-dose steroids on anastomotic complications after proctocolectomy with ileal pouch–anal anastomosis
     Jeffrey P Lake, Eiman Firoozmand, Jung‐Cheng Kang, Pantelis Vassiliu, Linda S. Chan, Petar Vukasin, Andreas M. Kaiser, Robert W. Beart · 2004 · Journal of Gastrointestinal Surgery
178. Sexual dysfunction following rectal excision for ulcerative colitis
     Rena May · 1966 · British journal of surgery
179. Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial
     Giuseppe D'Albasio, Omero Alessandro Paoluzi, Massimo Campieri, G PORRO, Angelo Pera, Cosimo Prantera, Giacomo Carlo Sturniolo, M. Miglioli, THEITALIANIBDSTUDYGROUP · 1998 · The American Journal of Gastroenterology
180. High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: Results of a meta-analysis of clinical trials
     Tessa E H Römkens, M T Milou Kampschreur, Joost P.H. Drenth, Martijn G.H. van Oijen, Dirk J. de Jong · 2012 · Inflammatory Bowel Diseases
181. Outcome of Patients With Indeterminate Colitis Undergoing a Double-Stapled Ileal Pouch-Anal Anastomosis
     Turab Pishori, A. Dinnewitzer, Oded Zmora, Michael Oberwalder, Luay Hajjar, Kathy Cotman, Anthony M. Vernava, Jonathan E. Efron, Eric G. Weiss, Juan J. Nogueras et al. · 2004 · Diseases of the Colon & Rectum
182. Total laparoscopic ileal pouch-anal anastomosis: prospective series of 82 patients
     Jérémie H. Lefèvre, Frederic Bretagnol, Mehdi Ouaïssi, Philippe Taleb, Arnaud Alvès, Yves H. Panis · 2008 · Surgical Endoscopy
183. A Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Mesalamine Suppositories 1 g at Bedtime and 500 mg Twice Daily in Patients with Active Mild-to-Moderate Ulcerative Proctitis
     Mark Lamet · 2010 · Digestive Diseases and Sciences
184. The place for colectomy and ileorectal anastomosis: a valid surgical option for ulcerative colitis?
     L. Börjesson, Ulf Lundstam, Tom Öresland, Hans Brevinge, Leif Hultén · 2006 · Techniques in Coloproctology
185. Coated Oral 5-Aminosalicylic Acid (Claversal) Is Equivalent to Sulfasalazine for Remission Maintenance in Ulcerative Colitis
     Sandro Ardizzone, M. Petrillo, P. Molteni, S. Desideri, Gabriele Bianchi Porro · 1995 · Journal of Clinical Gastroenterology
186. Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis
     Wolfgang Kruis · 2005 · World Journal of Gastroenterology
187. Preliminary data on the use of apheresis in inflammatory bowel disease
     William J. Sandborn · 2005 · Inflammatory Bowel Diseases
188. Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines
     Andrea Walch, Miena Meshkat, Harald Vogelsang, Gottfried Novacek, Clemens Dejaco, Sieglinde Angelberger, Andrea Mikulits, Wolfgang Miehsler, Alfred Gangl, Walter Reinisch · 2010 · Journal of Crohn s and Colitis
189. Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus
     Klaus R. Herrlinger, Daniel Nicolas Barthel, K. J. Schmidt, Jürgen Büning, Chris Barthel, Jan Wehkamp, EF Stange, Klaus Fellermann · 2010 · Alimentary Pharmacology & Therapeutics
190. The risk of rectal carcinoma following colectomy in ulcerative colitis
     William R. Johnson, Francis T. McDermott, Edward S. R. Hughes, E. Pihl, Barrie J. Milne, A. B. Price · 1983 · Diseases of the Colon & Rectum
191. Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. The Danish Olsalazine Study Group.
     Søren Kiilerich, K. Ladefoged, Terje Rannem, P Ranløv · 1992 · Gut
192. Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals
     Christian Mortensen, Sarah Caspersen, Niels Lyhne Christensen, Lise Svenningsen, Niels Thorsgaard, Lisbet Ambrosius Christensen, Flemming Bendtsen · 2010 · Journal of Crohn s and Colitis
193. To Divert or Not to Divert
     Richard E. Lovegrove · 2011 · Archives of Surgery
194. Colectomy for acute colitis: is it safe to close the rectal stump?
     Ruth F. McKee, R. A. Keenan, A. Munro · 1995 · International Journal of Colorectal Disease
195. Comparison of the efficacy and safety of Eudragit‐L‐coated mesalazine tablets with ethylcellulose‐coated mesalazine tablets in patients with mild to moderately active ulcerative colitis
     Peter G. Gibson, B Fixa, B. Pekárková, M Bátovský, Graham L Radford‐Smith, J. TIBITANZL, Libor Gabalec, Timothy H. Florin, Roland Greinwald · 2006 · Alimentary Pharmacology & Therapeutics
196. Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis
     Sangeetha Thanaraj, Peter John Hamlin, Alexander Charles Ford · 2010 · Alimentary Pharmacology & Therapeutics
197. Effect of Ecabet Sodium Enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study
     Toru Kono, Masafumi Nomura, Shinichi Kasai, Yutaka Kohgo · 2001 · The American Journal of Gastroenterology
198. Review article: high‐dose aminosalicylates to induce and maintain remissions in ulcerative colitis
     S. Hanauer · 2006 · Alimentary Pharmacology & Therapeutics
199. Efficacy of TNF Antagonists Beyond One Year in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Review
     Abderrahim Oussalah, Silvio Danese, Laurent Peyrin‐Biroulet · 2010 · Current Drug Targets
200. Conversion of the failing ileoanal pouch to reservoir-ileostomy rather than to ileostomy alone
     K. W. Ecker, M Haberer, G. Feifel · 1996 · Diseases of the Colon & Rectum